Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist

Gynecol Endocrinol. 2011 Aug;27(8):558-61. doi: 10.3109/09513590.2010.501887. Epub 2010 Jul 20.

Abstract

The aim of this study was to evaluate the relationship of oestradiol level on the day of hCG (peak E2)/oocyte ratio and the outcome of ART cycles. Of the patients who underwent IVF-ET, 600 normal and high responders to the first cycle of COH with gonadotropin releasing hormone (GnRH)-agonist were included in the study. Patients were designated into three groups based on peak E2/oocyte ratio (Group A: <100 pg/ml per oocyte, Group B: 100-200 pg/ml per oocyte, Group C: >200 pg/ml per oocyte). A comparison among groups was made regarding ovarian stimulation characteristics, fertilisation, implantation and pregnancy rates. After the division based on E2/oocyte ratio, in Group C, the number of oocytes retrieved, 2PN and M2 oocyte were statistically lower than both of the other two groups (p = 0.001, 0.001, 0.001, 0.045). HCG day E2 level was significantly different in all groups (p = 0.001), and fertilisation rate was meaningfully highest in Group C and lowest in Group A (p = 0.001). No difference existed among the three groups with respect to the number of embryos transferred and implantation rates. However, clinical pregnancy rate was significantly lower in Group A than others (p = 0.04). In ART cycles suppressed by GnRH-agonist, IVF outcomes are lower in patients with an E2/oocyte proportion of <100 pg/ml per oocyte.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Algorithms
  • Chorionic Gonadotropin / therapeutic use
  • Embryo Transfer
  • Estradiol / blood*
  • Female
  • Fertility Agents, Female / therapeutic use
  • Fertilization in Vitro
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Infertility / blood
  • Infertility / therapy
  • Leuprolide / therapeutic use
  • Medical Records
  • Oocytes / drug effects
  • Oogenesis / drug effects*
  • Ovulation Induction
  • Pregnancy
  • Pregnancy Rate
  • Reproductive Techniques, Assisted*
  • Retrospective Studies
  • Young Adult

Substances

  • Chorionic Gonadotropin
  • Fertility Agents, Female
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Leuprolide